» Articles » PMID: 2918869

The Cloned Human DNA Excision Repair Gene ERCC-1 Fails to Correct Xeroderma Pigmentosum Complementation Groups A Through I

Overview
Journal Mutat Res
Publisher Elsevier
Specialty Genetics
Date 1989 Mar 1
PMID 2918869
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The human DNA excision repair gene ERCC-1 complements the ultraviolet light (UV) and mitomycin C (MMC) sensitivity of CHO mutants of complementation group 1. We have investigated whether ERCC-1 is the mutated gene in cell lines from xeroderma pigmentosum (XP) complementation groups A through I by analyzing the endogenous gene in XP cells and by introduction of the gene followed by repair assays. Our studies show that ERCC-1 is not deleted or grossly rearranged in representative cell lines of 9 XP groups. Furthermore, Northern blot analysis revealed correct transcription of ERCC-1 in all groups. The cloned human ERCC-1 gene was introduced into immortalized XP cells by DNA transfection (groups A, C, D, E and F). The presence of the integrated transfected sequences was verified on Southern blots and by selection for 2 dominant marker genes that flank the ERCC-1 gene on the transfected cos43-34 DNA. ERCC-1 failed to confer a normal UV survival and UV-induced unscheduled DNA synthesis (UDS) to transfected populations. In the case of the remaining XP complementation groups (B, G, H and I), nuclear microinjection was used to introduce an ERCC-1 cDNA construct driven by an SV40 promoter into primary fibroblasts. Coinjection of the SV40 large T gene and analysis of its expression served as a control for the injection. The ERCC-1 cDNA failed to induce increased levels of UDS in the microinjected fibroblasts. We infer from these experiments that ERCC-1 is not the mutated gene in the 9 XP complementation groups examined. From a similar type of experiments we conclude that ERCC-1 is not the defective gene in UV-sensitive Cockayne's syndrome cells.

Citing Articles

Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.

Arora S, Kothandapani A, Tillison K, Kalman-Maltese V, Patrick S DNA Repair (Amst). 2010; 9(7):745-53.

PMID: 20418188 PMC: 4331052. DOI: 10.1016/j.dnarep.2010.03.010.


The ERCC1/XPF endonuclease is required for efficient single-strand annealing and gene conversion in mammalian cells.

Al-Minawi A, Saleh-Gohari N, Helleday T Nucleic Acids Res. 2007; 36(1):1-9.

PMID: 17962301 PMC: 2248766. DOI: 10.1093/nar/gkm888.


Correction of liver dysfunction in DNA repair-deficient mice with an ERCC1 transgene.

Selfridge J, Hsia K, Redhead N, Melton D Nucleic Acids Res. 2001; 29(22):4541-50.

PMID: 11713303 PMC: 92547. DOI: 10.1093/nar/29.22.4541.


The structure-specific endonuclease Ercc1-Xpf is required for targeted gene replacement in embryonic stem cells.

Niedernhofer L, Essers J, Weeda G, Beverloo B, de Wit J, Muijtjens M EMBO J. 2001; 20(22):6540-9.

PMID: 11707424 PMC: 125716. DOI: 10.1093/emboj/20.22.6540.


Transcription and DNA damage: a link to a kink.

Scicchitano D, Mellon I Environ Health Perspect. 1997; 105 Suppl 1:145-53.

PMID: 9114283 PMC: 1470299. DOI: 10.1289/ehp.97105s1145.